Pedro Mendes-Bastos
Overview
Explore the profile of Pedro Mendes-Bastos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
297
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zouboulis C, Passeron T, Pariser D, Wozniak M, Li X, Uhlmann L, et al.
Br J Dermatol
. 2024 Mar;
190(6):836-845.
PMID: 38470171
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease associated with a substantial disease burden. Secukinumab has previously been reported to have sustained efficacy with a favourable safety profile...
12.
Magarreiro-Silva A, Pimenta R, Gouveia A, Mendes-Bastos P
J Dtsch Dermatol Ges
. 2024 Mar;
22(5):704-705.
PMID: 38470157
No abstract available.
13.
From PsO to PsA: the role of T and Tregs in psoriatic disease, a systematic review of the literature
Lobao B, Lourenco D, Giga A, Mendes-Bastos P
Front Med (Lausanne)
. 2024 Feb;
11:1346757.
PMID: 38405187
Introduction: Psoriasis (PsO) is a chronic skin condition driven by immune mediators like TNFα, INFγ, IL-17, and IL-23. Psoriatic arthritis (PsA) can develop in PsO patients. Although psoriatic lesions may...
14.
Eyerich K, Gooderham M, Silvestre J, Shumack S, Mendes-Bastos P, Aoki V, et al.
J Eur Acad Dermatol Venereol
. 2023 Sep;
38(2):340-353.
PMID: 37669868
Background: Atopic dermatitis (AD), a relapsing, inflammatory skin disease, is associated with pruritus that can negatively affect patients' quality of life. Understanding the burden of AD is critical for informing...
15.
Paller A, Ladizinski B, Mendes-Bastos P, Siegfried E, Soong W, Prajapati V, et al.
JAMA Dermatol
. 2023 Apr;
159(5):526-535.
PMID: 37043227
Importance: Atopic dermatitis onset usually occurs in childhood. Persistence of disease into adolescence and adulthood is common. It is important to evaluate new treatment options in adolescents because of the...
16.
Mendes-Bastos P, Martorell A, Bettoli V, Matos A, Muscianisi E, Wortsman X
Br J Dermatol
. 2023 Feb;
188(5):591-600.
PMID: 36753411
Hidradenitis suppurativa (HS) is a chronic, inflammatory follicular skin disease that frequently affects the apocrine gland-bearing skin of the axillary, inguinal and anogenital regions. HS has a significant impact on...
17.
Kimball A, Jemec G, Alavi A, Reguiai Z, Gottlieb A, Bechara F, et al.
Lancet
. 2023 Feb;
401(10378):747-761.
PMID: 36746171
Background: Few therapeutic options are available for patients with moderate-to-severe hidradenitis suppurativa. We aimed to assess the efficacy of secukinumab in patients with moderate-to-severe hidradenitis suppurativa in two randomised trials....
18.
Torres T, Filipe P, Menezes Brandao F, Figueiredo A, Pinto Soares A, Sousa Basto A, et al.
Acta Med Port
. 2023 Jan;
36(9):541-549.
PMID: 36608696
Introduction: Psoriasis is a common, chronic, and inflammatory skin disorder with a high personal, social and economic burden and important implications for healthcare systems. The aim of this study was...
19.
Mendes-Bastos P, Ladizinski B, Guttman-Yassky E, Jiang P, Liu J, Prajapati V, et al.
J Am Acad Dermatol
. 2022 Jun;
87(4):784-791.
PMID: 35714786
Background: Acne is the most frequent adverse event associated with upadacitinib treatment in patients with moderate-to-severe atopic dermatitis. Objective: To characterize the adverse event of acne associated with upadacitinib. Methods:...
20.
Mendes-Bastos P, Morais P, Ferreira P, Loureiro M, Sanganha J, Santiago L, et al.
Dermatol Ther
. 2022 Apr;
35(7):e15510.
PMID: 35419886
To characterize moderate to severe psoriasis (PsO) adult patients treated with secukinumab, estimate drug persistence and assess any reasons for treatment discontinuation. Non-interventional, retrospective, longitudinal record-based study including patients diagnosed...